- Home
- EVTV vs RDHL Comparison
EVTV vs RDHL Comparison
Compare EVTV & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- RDHL
- Stock Information
- Founded
- EVTV 2012
- RDHL 2009
- Country
- EVTV United States
- RDHL Israel
- Employees
- EVTV N/A
- RDHL N/A
- Industry
- EVTV Auto Manufacturing
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- RDHL Health Care
- Exchange
- EVTV Nasdaq
- RDHL Nasdaq
- Market Cap
- EVTV 5.1M
- RDHL 4.3M
- IPO Year
- EVTV 2017
- RDHL N/A
- Fundamental
- Price
- EVTV $0.17
- RDHL $2.10
- Analyst Decision
- EVTV
- RDHL
- Analyst Count
- EVTV 0
- RDHL 0
- Target Price
- EVTV N/A
- RDHL N/A
- AVG Volume (30 Days)
- EVTV 1.7M
- RDHL 18.8K
- Earning Date
- EVTV 08-13-2025
- RDHL 08-28-2025
- Dividend Yield
- EVTV N/A
- RDHL N/A
- EPS Growth
- EVTV N/A
- RDHL N/A
- EPS
- EVTV N/A
- RDHL N/A
- Revenue
- EVTV $1,650,137.00
- RDHL $8,042,999.00
- Revenue This Year
- EVTV N/A
- RDHL $381.91
- Revenue Next Year
- EVTV N/A
- RDHL N/A
- P/E Ratio
- EVTV N/A
- RDHL N/A
- Revenue Growth
- EVTV N/A
- RDHL 23.17
- 52 Week Low
- EVTV $0.15
- RDHL $1.71
- 52 Week High
- EVTV $2.61
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- EVTV 41.47
- RDHL 61.27
- Support Level
- EVTV $0.17
- RDHL $2.00
- Resistance Level
- EVTV $0.20
- RDHL $2.08
- Average True Range (ATR)
- EVTV 0.02
- RDHL 0.09
- MACD
- EVTV 0.00
- RDHL 0.03
- Stochastic Oscillator
- EVTV 37.41
- RDHL 100.00
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.